DNA takes mystery out of medicine

New field of genomics helped crack patient’s baffling case and shed light on future of health care

Asha Perera dreamed of a career in music.

Playing the piano had brought her joy since she was eight years old. She always turned to music for comfort.

She especially loved Mozart’s Sonata in C Major. Its playful nature distracted her from life’s problems.

About 20 years ago, Perera followed her passion to college, where she discovered a talent for singing. Caro mio ben, an emotional love song, quickly became one of her favourite melodies.

Then the insomnia and attacks of extreme anxiety began. Her suffering was traced to polycystic ovarian syndrome, which causes a chemical imbalance in the body. A doctor prescribed her a new medication but within hours of taking it she noticed problems with her hand-eye coordination. She was told she needed to take the drug for six months to improve her condition.

Jules Knox
The Province
Read More

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below